tripelennamine has been researched along with Angiomatosis in 1 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Angiomatosis: A condition with multiple tumor-like lesions caused either by congenital or developmental malformations of BLOOD VESSELS, or reactive vascular proliferations, such as in bacillary angiomatosis. Angiomatosis is considered non-neoplastic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| OPPENHEIM, M | 1 |
| YACULLO, WA | 1 |
1 other study available for tripelennamine and Angiomatosis
| Article | Year |
|---|---|
Generalized angiomatosis simplex cutis following an erythema morbilliforme probably caused by the use of pyribenzamine.
Topics: Angiomatosis; Erythema; Skin; Skin Diseases; Tripelennamine | 1948 |